Search research articles
Contact Us
Filters
Showing results (101-110 of 524) with videos related to
Page
of 53
Sort By:
Bollettino Della Societa Italiana Di Biologia Sperimentale
|
February 28, 1970
[Study of the survival of the non-proliferative fraction of blast cells of acute leukemia]
V Gabutti, P Masera, R P Tarocco, et al.
Expert Review of Hematology
|
September 21, 2012
Blastic plasmacytoid dendritic cell neoplasm: is it time to redefine the standard of care?
Pier Paolo Piccaluga, Stefania Paolini, Maria Rosaria Sapienza, et al.
Clinical Case Reports
|
January 27, 2025
Cutaneous involvement in multiple myeloma. A rare entity
L Rapparini, A Pileri, S Robuffo, et al.
Haematologica
|
March 8, 2005
The development of more than one histologic type of lymphoma in the same patient is frequent and confers a worse prognosis
Stefano A Pileri, Pier Paolo Piccaluga, Elena Sabattini, et al.
Human Pathology
|
August 19, 2008
HIV infection and c-MYC status in endemic Burkitt lymphoma
Cristina Campidelli, Anna Gazzola, Francesca Vitone, et al.
Journal of Clinical Pathology
|
March 16, 2002
Hodgkin's lymphoma: the pathologist's viewpoint
S A Pileri, S Ascani, L Leoncini, et al.
European Journal of Haematology
|
January 1, 1991
Dipyridamole in vitro suppresses the generation of T-cell cytotoxic functions: synergistic activity with cyclosporine
M Massaia, A Bianchi, C Attisano, et al.
Pharmacological Research
|
September 1, 1992
Cyclosporin A and dipyridamole: an effective combination against the generation of cytotoxic T lymphocytes (CTL)
M Massaia, A Bianchi, C Attisano, et al.
Medical Oncology (Northwood, London, England)
|
August 30, 2000
Rituximab anti-CD20 monoclonal antibody induces marked but transient reductions of peripheral blood lymphocytes in chronic lymphocytic leukaemia patients
M Ladetto, L Bergui, I Ricca, et al.
Leukemia Research
|
November 26, 1999
Modulation of in vitro chemosensitivity in acute myelogenous leukemia cell line by GM-CSF: opposing effects observed with different cytotoxic drugs and time exposure
C Ciaiolo, D Ferrero, A Pugliese, et al.
Page
of 53
Search research articles
Search
Showing results (101-110 of 524) with videos related to
Sort By:
Page
of 53
Bollettino Della Societa Italiana Di Biologia Sperimentale
|
February 28, 1970
[Study of the survival of the non-proliferative fraction of blast cells of acute leukemia]
V Gabutti, P Masera, R P Tarocco, et al.
Expert Review of Hematology
|
September 21, 2012
Blastic plasmacytoid dendritic cell neoplasm: is it time to redefine the standard of care?
Pier Paolo Piccaluga, Stefania Paolini, Maria Rosaria Sapienza, et al.
Clinical Case Reports
|
January 27, 2025
Cutaneous involvement in multiple myeloma. A rare entity
L Rapparini, A Pileri, S Robuffo, et al.
Haematologica
|
March 8, 2005
The development of more than one histologic type of lymphoma in the same patient is frequent and confers a worse prognosis
Stefano A Pileri, Pier Paolo Piccaluga, Elena Sabattini, et al.
Human Pathology
|
August 19, 2008
HIV infection and c-MYC status in endemic Burkitt lymphoma
Cristina Campidelli, Anna Gazzola, Francesca Vitone, et al.
Journal of Clinical Pathology
|
March 16, 2002
Hodgkin's lymphoma: the pathologist's viewpoint
S A Pileri, S Ascani, L Leoncini, et al.
European Journal of Haematology
|
January 1, 1991
Dipyridamole in vitro suppresses the generation of T-cell cytotoxic functions: synergistic activity with cyclosporine
M Massaia, A Bianchi, C Attisano, et al.
Pharmacological Research
|
September 1, 1992
Cyclosporin A and dipyridamole: an effective combination against the generation of cytotoxic T lymphocytes (CTL)
M Massaia, A Bianchi, C Attisano, et al.
Medical Oncology (Northwood, London, England)
|
August 30, 2000
Rituximab anti-CD20 monoclonal antibody induces marked but transient reductions of peripheral blood lymphocytes in chronic lymphocytic leukaemia patients
M Ladetto, L Bergui, I Ricca, et al.
Leukemia Research
|
November 26, 1999
Modulation of in vitro chemosensitivity in acute myelogenous leukemia cell line by GM-CSF: opposing effects observed with different cytotoxic drugs and time exposure
C Ciaiolo, D Ferrero, A Pugliese, et al.
Page
of 53